• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, September 6, 2024

News
Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A roundup from UNC Health included a video interview published on AJMC.com, the website of The American Journal of Managed Care®. The interview, “Using Active Surveillance to Spare Men From Unneeded Prostate Cancer Treatment,” featured Matthew Nielsen, MD, FACS, chair of the Department of Urology at the University of North Carolina, speaking about how active surveillance in prostate cancer can avoid unnecessary care that could affect the quality of life of a patient.

Related Videos
Tiago Biachi, MD, PhD
1 expert is featured in this series.
5 experts are featured in this series.
5 experts are featured in this series
1 expert is featured in this series.
Related Content
Tim Mok, PharmD

Dr Tim Mok: A Pharmacist's Perspective on Balancing Costs and Outcomes

January 4th 2025
Article

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

Read More

AJMC Managed Care Cast

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

December 31st 2024
Podcast

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

Listen

A new post-hoc analysis showed patients with generalized myasthenia gravis and acetylcholine-receptor autoantibodies saw sustained improvement on efgartigimod. | Image credit: syahrir-stock.adobe.com

Efgartigimod Leads to Sustained Myasthenia Gravis Improvement

January 4th 2025
Article

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.

Read More

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

December 26th 2024
Podcast

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Listen

Better understanding the vascular sequelae of MS may similarly unlock predictive insights for people with MS, according to investigators. | Image credit: Elena - stock.adobe.com

Meta-Analysis: Vascular Function Worse in People With MS

January 3rd 2025
Article

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

Read More

Woman taking eye exam | Image credit: Rabizo Anatolii - stock.adobe.com

Response Times to Visual Stimulus Slower in Patients With Glaucoma

January 3rd 2025
Article

When compared with auditory stimulus, patients with glaucoma had slower response times to visual stimulus.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.